LFVNNasdaqPharmaceutical PreparationsFiscal year ends December 31
Lifevantage Corp
Financials through Q4 FY2026, quarter ended Jun 30, 2026Last filing: 10-K on Aug 27, 2026
$5.98−0.02 (-0.33%)
Close on Oct 19, 2026
- Market cap
- $74.97M
- P/E (TTM)
- 15.0
- Dividend yield
- 3.09%
Dividends
Dividend declared per share by fiscal year, adjusted for stock splits
Per share, FY2026
$0.18
+12.1% on the prior year
Consecutive increases
1 year
Every year since FY2025
Dividend yield
3.09%
Latest annual dividend ÷ share price
Payout ratio, FY2026
46.2%
Dividends paid ÷ net income
Dividend history
By fiscal year
| Fiscal year | Per share | Change | Cash paid | Payout ratio |
|---|---|---|---|---|
| FY2026 | $0.18 | +12.1% | $2.34M | 46.2% |
| FY2025 | $0.17 | -69.7% | $2.07M | 21.1% |
| FY2024 | $0.55 | +336.0% | $6.94M | 236.3% |
| FY2023 | $0.13 | +316.7% | $1.59M | 62.4% |
| FY2022 | $0.03 | – | $378.00K | 12.1% |
Ex-dividend and payment dates for each distribution will appear once a dividend calendar source is connected.